Ivermectin for Post Exposure Prophylaxis of Covid-19
Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
Post exposure prophylaxis of healthy contacts is among the measures used for outbreak control
of several infectious diseases (e.g., pandemic influenza). No agent is known to be effective
in preventing COVID-19, but Ivermectin is one of the drugs that have shown antiviral activity
against SARS-CoV-2 in the laboratory. This study aims to evaluate the effect of post exposure
prophylaxis with Ivermectin after exposure to COVID-19 among the asymptomatic close contacts.